Impact Factor
3.88
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.13
5,484 total citations
h5-index
92
h5 depth signal
Cited share
41.0%
564 of 1,375
Total citations
5,484
Citation footprint
Metric signal
3.76
External metric anchor
Self-citation
3.6%
197 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
4,856
China
683
United Kingdom
588
Canada
405
Germany
391
Citing Fields of Research
Cardiology
2,815
Urology
1,489
Physiology
1,289
Diabetes
1,273
Kidney Diseases
1,153
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
24,106
Articles tracked across the journal lifetime
Indexed publication set
1,375
564 cited publications
Last 12 months
353
29.4 publications/month
Open access share
19.3%
68 OA publications in the last year
Leading citing country
United States
4,856 citing publications
Leading citing field
Cardiology
2,815 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
Active Coverage
v1n1,Jan./Feb. 1979-
v1n1,Jan./Feb. 1979-
Active Coverage
Research Focus & Classification
Indexed Subjects
Cardiology
Obstetrics/Gynecology
Urology
Kidney Diseases
Diabetes
Physiology
Issuing & Sponsoring Bodies
Contributor
American Heart Association
Contributor
Council for High Blood Pressure Research (American Heart Association)
Contributor
Interamerican Society of Hypertension. Scientific Meeting
Broad Categories
Vascular Diseases
Urology
MeSH Descriptors
Hemodynamics
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1161/hypertensionaha.126.27798
Open DOI
Aldosterone-Producing Lesions Harboring ATP1A1 and ATP2B3 Mutations: An International Multicenter Study
BACKGROUND: Somatic aldosterone-driver mutations are identified in >90% of patients with primary aldosteronism undergoing adrenalectomy, and they display distinct demographic clustering. ATP1A1 and ATP2B3 mutations, encoding the Na + /K ...
02
DOI 10.1161/hypertensionaha.126.27232
Open DOI
Glycosylated Fibronectin Compared With sFlt-1/PlGF Ratio for Preeclampsia Assessment
BACKGROUND: The ratio of sFlt-1 (soluble fms-like tyrosine kinase 1) to PlGF (placental growth factor) is an established biomarker for preeclampsia diagnostic triage. GlyFn (glycosylated fibronectin) measured by point-of-care testing is ...
03
DOI 10.1161/hypertensionaha.125.26418
Open DOI
Inhibition of ROCK2 via KD025/Belumosudil Alleviates Hypertensive End-Organ Damage
BACKGROUND: Despite achieving target blood pressure, hypertensive individuals have an elevated risk of cardiovascular disease, likely due to unresolved inflammation. Thus, adjunctive immune-modulating therapies are needed to protect pati...
04
DOI 10.1161/hypertensionaha.126.27758
Open DOI
Cautionary Data on Antihypertensives in Aortic Diseases
05
DOI 10.1161/hypertensionaha.126.27742
Open DOI
Brief Commentary on Blood Pressure, Pulse Wave Velocity, and Body Composition in Children and Adolescents
06
DOI 10.1161/hypertensionaha.126.27749
Open DOI
TSP-1 Endothelial Signaling Impairs Brain Angiogenesis in Preeclampsia
BACKGROUND: Preeclampsia adversely affects fetal brain angiogenesis, with potential acute and long-term consequences. However, the mechanisms underlying these cerebrovascular alterations remain unclear. We investigated whether TSP-1 (thr...
07
DOI 10.1161/hypertensionaha.125.26375
Open DOI
Glycemia, Insulin Sensitivity Markers and Arterial Stiffness: The Framingham Heart Study
BACKGROUND: There is limited data on the associations of (glycated hemoglobin A1C [HbA 1C ], fasting plasma glucose, and 2-hour postload glucose) and insulin resistance (fasting plasma insulin, insulin-to-glucose ratio, homeostasis model...
08
DOI 10.1161/hypertensionaha.126.25708
Open DOI
2024 Donald Seldin Lecture: New Insights Into Soluble (Pro)Renin Receptor in Hypertension and Kidney Disease
Also known as ATP6AP2, the PRR ([pro]renin receptor) was originally cloned over 2 decades ago as a component of the renin-angiotensin system due to its property of nonproteolytic activation of prorenin. After heated debates, this concept...
09
DOI 10.1161/hypertensionaha.126.26909
Open DOI
Regression of Left Ventricular Hypertrophy in Primary Aldosteronism
BACKGROUND: Left ventricular hypertrophy (LVH) is frequently identified in patients with primary aldosteronism; determinants of LVH regression after targeted treatment are debated. We assessed LVH prevalence before and after adrenalectom...
10
DOI 10.1161/hypertensionaha.126.27702
Open DOI
Professor John Low Reid, OBE, DM, FRCP, FRSE, FMedSci
Bibliographical & Catalog Notes
Online version has title: Hypertension online.
Title from cover.
Vols. for July/Aug. 1980?- include as pt. 2, American Heart Association Monograph ; no. 70, etc.
Has annual supplement with title: Proceedings of the Council for High Blood Pressure Research; has biennial supplement with title: Proceedings of the ... Scientific Meeting of the Interamerican Society of Hypertension, <1981->; also has occasional additional supplements.
Supplements for 1987- also called: Monograph, no. 1-
Also issued to online
An official journal of: the American Heart Association.
Some no. also issued as American Heart Association monograph, 19 -85; and, Monograph (American Heart Association), 1986.
Absorbed: Hypertension, with supplement to v. 1, no. 3 in 1979.
Vol. 14, no. 2 (AUG 1989)19900918 Notice published Printed on acid-free paper